New injection for year-round nasal allergies
Treatments studied
Part of Ear, nose & throat, Immune system & allergy, Lungs & breathing clinical trials.
This study tests a new injection called JYB1904 for people with year-round nasal allergies. It may help reduce symptoms like sneezing, stuffy nose, and runny nose.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have been diagnosed with year-round allergic rhinitis (nasal allergies) for at least 2 years.
- You have been using a daily nasal steroid spray (like Flonase or Nasonex) for at least 4 weeks before starting the study.
- You have a positive skin prick test or blood test for indoor allergens (like dust mites, pet dander, or mold).
- You are willing to use an electronic diary (eDiary) every day.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a special probiotic blend can help people with year-round allergic rhinitis (nasal allergies) caused by common indoor allergens like dust mites, cat, or dog dander. Volunteers will take the probiotic daily and track their symptoms.
This trial tests a new nasal spray for people with perennial (year-round) allergic rhinitis. It aims to see if the medicine works well and is safe compared to other treatments.
This trial tests a new injection called GR1802 for people with seasonal allergic rhinitis (hay fever) that isn't well controlled by standard treatments. It aims to see if this medicine can help reduce symptoms during pollen season.
This study tests a new injection called MG-K10 for people with moderate-to-severe seasonal hay fever that isn't well controlled by standard treatments like nasal sprays or antihistamines. The goal is to see if it can reduce your allergy symptoms over the pollen season.
This study tests a new injection called JYB1904 to help adolescents with allergic diseases like food allergies, hay fever, allergic asthma, or chronic hives. Researchers want to learn if it's safe and how well it works.
This study tests an investigational injection called TQH2722 combined with standard allergy therapy for seasonal allergic rhinitis (hay fever). It may help people whose allergy symptoms are not well controlled during pollen season.
Hear when a new Perennial Allergic Rhinitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.